About: http://data.cimple.eu/news-article/d488f62ddd3308d0316dbaa42ce3924bf61c7d687f97c05f51504538

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/d488f62ddd3308d0316dbaa42ce3924bf61c7d687f97c05f51504538 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	South Africa rolls out the continent's first coronavirus vaccine trial this week, the university leading the pilot said Tuesday, as the country grapples with the highest number of cases in Africa. The vaccine, developed by the Oxford Jenner Institute, is already being evaluated in the United Kingdom, where 4,000 participants have signed up for the trial. South Africa has set out to vaccinate 2,000 people with the vaccine known as ChAdOx1 nCoV-19. Fifty of the candidates have HIV. "We began screening participants for the South African Oxford 1 Covid-19 vaccine trial last week, and the first participants will be vaccinated this week," said University of Witwatersrand (Wits) vaccinology professor Shabir Madhi at a virtual press conference. Brazil is planning its own pilot, while the United States is preparing to test another vaccine in a mass trial of up to 30,000 participants. Wits is collaborating with the University of Oxford and the Oxford Jenner Institute on the South African trial. South Africa's coronavirus cases jumped to over 100,000 on Monday, while the number of deaths inched towards 2,000. Officials implemented a strict nationwide lockdown on March 27, just weeks after the virus first hit South Africa. But confinement measures are being gradually phased out to allow business to pick up and limit damage to an already ailing economy. "As we enter winter in South Africa and pressure increases on public hospitals, now more than ever we need a vaccine to prevent infection by COVID-19," Madhi said, describing the vaccine trial as a "landmark moment". South African health officials have also placed high hopes on dexamethasone, a generic anti-inflammatory drug found to reduce mortality among ventilated patients. "This is one of those medicines where we do have excellent local capacity," said Health Minister Zweli Mkhize in a statement last week. South African pharmaceutical giant Aspen Pharmacare has said it was ready to scale up production of the steroid. sch/sn/jj
schema:headline	S.Africa to start Africa's first coronavirus vaccine pilot
schema:mentions	Dexamethasone Corticosteroid Anti-inflammatory Cancer screening Medication Mortality rate Ebola virus disease University of Oxford Africa HIV Lockdown South Africa United Kingdom Brazil Vaccine United States Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Aspen Pharmacare Shabir Edward Jenner University of the Witwatersrand Zweli Mkhize
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-06-23 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	neutral sentiment
http://data.cimple...readability_score	79 (xsd:integer)
http://data.cimple...tology#hasEmotion	happiness

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software